Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Octapharma USA’s IND application to begin trial with severe Covid-19 patients
The FDA has approved Octapharma USA’s IND application to begin trial with severe Covid-19 patients. (Credit: PIRO4D from Pixabay)
The FDA has approved Octapharma USA’s IND application to begin trial with severe Covid-19 patients. (Credit: PIRO4D from Pixabay)